Calcium salt of (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl)sulfonyl]-(isobutyl)amino]-1-benzyl-2-(phosphonooxy) propylcarbamate, pharmaceutical composition containing the compound and process for preparation the same

The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-ÄÄ(4-aminophenyl)sulfonylÜ(isobutyl)amin oÜ-1-benzyl-2-(phosphonooxy) propylcarbamate combined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-Ä2-(1-methylethyl)4-thiazolylÜ -3,6-dioxo-8,1 1-bis(phenylmethyl)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ARMITAGE IAN GORDON ARLESEY, SEARLE ANDREW DAVID STEVENAGE, SINGH HARDEV DARTFORD
Format:	Patent
Sprache:	eng ; hun
Schlagworte:	ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-ÄÄ(4-aminophenyl)sulfonylÜ(isobutyl)amin oÜ-1-benzyl-2-(phosphonooxy) propylcarbamate combined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-Ä2-(1-methylethyl)4-thiazolylÜ -3,6-dioxo-8,1 1-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid, 5-thiazolylmethyl ester (ritonavir), and to the use thereof in the treatment of diseases caused by retroviruses.